Table 1 Correlation between SPIN1 expression and clinicopathological features
Variables | SPIN1 | P value | |
|---|---|---|---|
Low | High | ||
Age (years) | |||
  ≤ 50 | 19 | 21 |  |
  > 50 | 24 | 14 | 0.180 |
Tumor size (cm) | |||
  < 3 | 20 | 12 |  |
  ≥ 3 | 23 | 23 | 0.356 |
Lymph node metastases | |||
 Negative | 12 | 4 |  |
 Positive | 31 | 31 | 0.094 |
Chemosensitivity | |||
 Drug-sensitive | 28 | 11 |  |
 Drug-resistant | 15 | 24 | 0.006 |
ER | |||
 Negative | 18 | 9 |  |
 Positive | 25 | 26 | 0.158 |
PR | |||
 Negative | 22 | 13 |  |
 Positive | 21 | 22 | 0.257 |
HER2 | |||
 Negative | 24 | 20 |  |
 Positive | 13 | 9 | 0.796 |
 Missing | 12 |  | |
Ki-67 | |||
 Negative (< 14%) | 13 | 9 |  |
 Positive (≥14%) | 30 | 26 | 0.801 |
pT | |||
 0 | 2 | 0 |  |
 I | 13 | 11 |  |
 II | 24 | 16 |  |
 III | 3 | 8 |  |
 IV | 1 | 0 | 0.179 |
pN | |||
 0 | 12 | 5 |  |
 I | 13 | 4 |  |
 II | 11 | 14 |  |
 III | 7 | 12 | 0.035 |
Distant metastases | |||
 M0 | 40 | 34 |  |
 M1 | 3 | 1 | 0.623 |
pTNM stage | |||
 I + II | 23 | 9 |  |
 III + IV | 20 | 26 | 0.020 |